The two companies will combine existing assets in order to find new connections and opportunities. Many companies and ...

In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results ...

Effective February 10, 2025, Mamilli will assume global responsibility for the Informatics function for the Roche Group.

Essen Health Care announced that it is participating in the Guiding an Improved Dementia Experience (GUIDE) Model, an ...